Jinrui Ou

机构：Mudanjiang Medical University

发表论文 30 篇 · 总被引 396 次 · h-index 12

代表论文

• Surgical Management and Prognostic Factors of Hilar Cholangiocarcinoma: Experience with 115 Cases in China (2008 · Annals of Surgical Oncology · 被引 74)
• miR‐216a may inhibit pancreatic tumor growth by targeting JAK2 (2015 · FEBS Letters · 被引 61)
• The current surgical treatment of pancreatic cancer in China: a national wide cross-sectional study (2019 · Journal of Pancreatology · 被引 27)
• TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4 (2015 · PLoS ONE · 被引 26)
• miR‐186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1‐mediated Wnt/β‐catenin signaling (2019 · Journal of Cellular Physiology · 被引 21)
• The current surgical treatment of pancreatic neuroendocrine neoplasms in China: a national wide cross-sectional study (2019 · Journal of Pancreatology · 被引 18)